PDF - 2023-05-08 Baxter International Inc. , a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma. | May 8, 2023
Unprecedented, and wholly unexpected deal volume in the last 12 months is creating significant challenges for Private Equity PE funds looking to invest in the healthcare sector.
Advent International, a private equity firm, is investing an undisclosed amount into Iodine boosting its valuation beyond $1 billion. The hope is that the company's AI-powered clinical documentation improvement software can capture a greater share of the market for software products that help hospitals code and bill accurately to receive reimbursement.